Evidence map›Paper›PMID 38317063›Full record

ArticleBMC ophthalmology2024

Microbiological isolates and associated complications of dacryocystitis and canaliculitis in a prominent tertiary ophthalmic teaching hospital in northern China.

Xiaobo Tian, Hua Sun, Yanfei Huang, Wenjun Sui, Dan Zhang, Yufeng Sun, Jing Jin, Yueqing He, Xinxin Lu

Abstract read
In one paragraph

Article in BMC ophthalmology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xiaobo TianDepartment of Laboratory Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing, 100176, China.
Hua SunDepartment of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, 100176, China.
Yanfei HuangDepartment of Laboratory Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing, 100176, China.
Wenjun SuiDepartment of Laboratory Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing, 100176, China.
Dan ZhangDepartment of Laboratory Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing, 100176, China.
Yufeng SunDepartment of Laboratory Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing, 100176, China.
Jing JinDepartment of Laboratory Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing, 100176, China.
Yueqing HeDepartment of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, 100176, China.
Xinxin LuDepartment of Laboratory Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing, 100176, China. luxinxin2009@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo report the microbiological isolates, aetiology, complications, antibiotic susceptibilities, and clinical remission of dacryocystitis and canaliculitis in a prominent tertiary ophthalmic teaching and referral hospital located in northern China and to offer appropriate recommendations for preventing and formulating drug treatment strategies.

methodsThis prospective study recruited a total of 477 participants who had been diagnosed with either dacryocystitis or canaliculitis. The cohort comprised 307 patients with chronic dacryocystitis, 111 patients with acute dacryocystitis, and 59 patients with canaliculitis. Purulent discharge from the lacrimal duct was collected using a sterile swab and immediately subjected to microbial culture. Antimicrobial susceptibility testing was conducted following established protocols. All participants were scheduled for follow-up visits within 14 days after receiving antibiotic therapy.

resultsThe present findings indicated that women exhibited a higher susceptibility to the condition, as evidenced by the occurrence of 367 cases in comparison to 110 cases among men. Among the 477 patients, definitive causes were established in 59 individuals, accounting for 12.4% of the patients. Additionally, ocular complications were reported by 132 patients, representing 27.7% of the total. Monocular involvement was observed in the majority of cases, with 402 out of 477 patients (84.3%) affected, while binocular involvement was present in 75 patients (15.7%). In total, 506 microbiological strains were recovered from 552 eyes, with Staphylococcus epidermidis (16.4%) being the most prevalent microorganism. Other predominant isolates included Corynebacterium macginleyi (9.1%), Staphylococcus aureus (5.1%), Streptococcus pneumoniae (4.9%), Haemophilus (4.4%), Propionibacterium acnes (3.5%), and Eikenella corrodens (3.1%). Among the 12 isolated fungi, Candida parapsilosis accounted for 66.7%. The susceptibility to antimicrobial agents tested in gram-negative bacilli (79.5%) was observed to be higher than that of anaerobic bacteria (76.7%) and gram-positive cocci (55.4%). With pharmacological therapy, the remission rate of acute dacryocystitis (72.7%) was found to be higher than that of canaliculitis (53.3%) and chronic dacryocystitis (42.3%).

conclusionsThis study highlights the microbial spectrum of dacryocystitis and canaliculitis, particularly C.macginleyi, E.corrodens and C.parapsilosis, which are also more frequently isolated. Vancomycin and imipenem may be more effective treatment options. Most cases have an unknown aetiology, and essential preventive measures involve postoperative cleansing of the lacrimal passage following eye and nasal surgeries, as well as the proactive management of rhinitis.

Indexed as

CanaliculitisDacryocystitisLacrimal ApparatusAnti-Bacterial AgentsFemaleHospitals, TeachingHumansMaleProspective StudiesAnti-Bacterial AgentsAntimicrobial susceptibilityCanaliculitisComplicationsDacryocystitisMicrobiologic isolates

Identifiers

PMID38317063
PMCPMC10840201

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.